Clinical lymphoma, myeloma & leukemia
Clin Lymphoma Myeloma Leuk
· ISSN (e) 2152-2669
· 1 paper in corpus
other
2017
BACKGROUND: Allogeneic stem cell transplantation (ASCT) represents the only option with a potential cure rate of 30% to 50% in myelodysplastic syndrome (MDS); however, < 5% of patients are optimal candidates for this management. Therapeutic…